FdaApplication

NDA 215212

Back to search

Identifiers

Properties

PropertyValue
applicant_nameHQ SPECIALTY PHARMA CORP
application_typeNDA
approval_date2023-07-26

Products (1)

ProductActive ingredientStrengthDosage form
MEROPENEMMEROPENEM2GM/VIALPOWDER;INTRAVENOUS

1 product